Gender differences in the prescription of <scp>SGLT2</scp> inhibitors in chronic kidney disease: A real‐world database study
Persistent gender disparities in SGLT2 inhibitor prescriptions highlight the need for healthcare providers worldwide to recognise potential gender biases and ensure equitable access to evidence-based CKD therapies. Addressing gender-based disparities is crucial for optimising CKD management globally.
Authors
- Norihiko Takeda (ORCID: https://orcid.org/0000-0003-1023-6116)
- Katsuhito Fujiu (ORCID: https://orcid.org/0000-0002-1889-9291)
- Yuta Suzuki (ORCID: https://orcid.org/0000-0002-9406-4691)
- Hidehiro Kaneko (ORCID: https://orcid.org/0000-0003-2553-6170)
- Norifumi Takeda (ORCID: https://orcid.org/0000-0003-4818-3347)
- Akira Okada (ORCID: https://orcid.org/0000-0001-6480-3388)
- Takashin Nakayama (ORCID: https://orcid.org/0000-0003-2498-2793)
- Kazuki Aoyama
- Masaomi Nangaku (ORCID: https://orcid.org/0000-0001-7401-2934)
- Kaori Hayashi (ORCID: https://orcid.org/0000-0002-4923-1550)
- Hiroyuki Morita (ORCID: https://orcid.org/0000-0003-0879-5576)
- Koichi Node (ORCID: https://orcid.org/0000-0002-2534-0939)
- Takashi Yokoo (ORCID: https://orcid.org/0000-0003-1838-7998)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Tatsuhiko Azegami (ORCID: https://orcid.org/0000-0002-4809-5788)
Institutions
- Jikei University School of Medicine (JP)
- Saga University (JP)
- Keio University (JP)
- National Institute of Public Health (JP)
- University of Tokyo Health Sciences (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1111/dom.70020
- Citations
- 2
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 2.59
Funders
- Ministry of Health, Labour and Welfare
- University of Tokyo